CASP3 and ovarian carcinoma: Increased expression of pro-apoptotic factor caspase 3 in wild type xenograft breast tumors, correlates with the work of Shen et al., (2015) who showed that Nos increases the anti-cancer activity of cisplatin in ovarian cancer cells SKOV3/DDP by modulating the cell cycle and activating apoptotic pathways44.